KSB SE & Co. KGaA Vz.A/ DE0006292030 /
21/05/2024 7:57:05 | Diferencia +2.0000 | Volumen | Bid13:08:05 | Ask13:08:05 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
632.0000EUR | +0.32% | - Volumen de negocios: - |
614.0000Volumen de oferta: 11 | 620.0000Tamaño/ Volumen/ Formato de Ask: 11 | 1.14 mil millonesEUR | 1.96% | 11.70 |
GlobeNewswire
13:15
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
GlobeNewswire
13:10
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession Licen...
GlobeNewswire
13:07
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
GlobeNewswire
13:05
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
13:00
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
GlobeNewswire
13:00
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
13:00
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
13:00
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on AB...
GlobeNewswire
13:00
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC)...
GlobeNewswire
13:00
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
GlobeNewswire
13:00
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
GlobeNewswire
13:00
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therap...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página